Clinical Trials Browser

Prostatic Neoplasms × mirabegron × Genitourinary × Clear all

NCT03600766 2019-09-04

Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

Phase 2 Unknown

Erectile Dysfunction, Prostatic Hyperplasia, Prostatic Neoplasms